Latest filing published 19 Feb 2025 for Elevation Oncology, Inc., €2,666.
Insider track record
No signal scores available.
David Dornan: trading record in brief
David Dornan discloses dealings in Elevation Oncology, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 15 February 2025, with 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 February 2025, reports a share grant of €2,666 in Elevation Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Dornan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,152 shares@ US$0.6717100.0% of flowCommon StockSEC:0001415889-25-004595:1
- 9,375 sharesCommon StockSEC:0001415889-25-004595:0
2 of 2 declarations